“The acquisition of this facility advances our leadership position in
pharmaceutical flexibles through growth in emerging markets,” said
Ilene Gordon, president and chief executive officer, Alcan Packaging.
The Chakan operations both expand Alcan Packaging’s geographic
footprint and strengthen the organization's strategic presence in the
Indian pharmaceutical market, which is currently ranked 14th in the
world in terms of scale and expected to triple over the next decade.
“Chakan is a well equipped plant with dynamic people and an asset base that will definitely complement our current product portfolio,” said Michael Schmitt, president of Alcan Global Pharmaceutical Packaging division. “The expertise with local pharmaceutical companies will be an excellent addition to our organization.” With annual sales of $3.6 million, the Chakan facility is a well-regarded supplier to the Indian pharmaceutical market. Its integration into the Alcan Packaging group is expected to be completed early in 2009.
“Chakan is a well equipped plant with dynamic people and an asset base that will definitely complement our current product portfolio,” said Michael Schmitt, president of Alcan Global Pharmaceutical Packaging division. “The expertise with local pharmaceutical companies will be an excellent addition to our organization.” With annual sales of $3.6 million, the Chakan facility is a well-regarded supplier to the Indian pharmaceutical market. Its integration into the Alcan Packaging group is expected to be completed early in 2009.
Companies in this article
